Determination of troponin I release after CABG surgery

Joseph Noora1, Christopher Ricci, Deborah Hastings

  • 1McMaster University, Hamilton, Ontario, Canada.

Journal of Cardiac Surgery
|February 24, 2005
PubMed

Insights

Coronary artery bypass graft surgery elevates troponin I levels, peaking postoperatively. Preoperative troponin I may predict elevated postoperative levels without myocardial infarction.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomarkers

Background:

  • Troponin I is a key biomarker for diagnosing myocardial infarction (MI).
  • The pattern and diagnostic utility of troponin I elevation after coronary artery bypass graft (CABG) surgery are not well-established.
  • This study investigates troponin I kinetics in patients undergoing urgent CABG.

Purpose of the Study:

  • To assess the timing and magnitude of troponin I elevation following urgent CABG.
  • To determine if troponin I elevation patterns differ between patients with and without perioperative myocardial infarction (PMI).
  • To identify predictors of elevated postoperative troponin I levels.

Main Methods:

  • Prospective study of 50 patients undergoing urgent isolated-CABG with cardiopulmonary bypass.
  • Serial measurements of troponin I, CK, and CK-MB preoperatively and at multiple postoperative time points (7h, 14-18h, 30-48h, day 4).
  • Perioperative MI (PMI) defined by ECG and/or CK-MB criteria.

Main Results:

  • 12% of patients (6/50) met criteria for PMI.
  • In patients without PMI, troponin I peaked at 7 hours post-op (mean 20.97 µg/L).
  • Patients with PMI had significantly higher troponin I levels at 7 hours post-op (mean 46.85 µg/L).
  • Preoperative troponin I was the only significant predictor of peak postoperative troponin I in patients without PMI.

Conclusions:

  • CABG surgery causes significant troponin I elevation, often exceeding diagnostic thresholds for MI, without actual MI occurrence.
  • Troponin I levels typically peak during the second postoperative day.
  • Elevated preoperative troponin I may indicate higher postoperative troponin I levels in patients without PMI, suggesting non-ischemic causes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...